The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reduction of Capital effective

31 Jan 2013 13:10

RNS Number : 8223W
Ipso Ventures PLC
31 January 2013
 



31 January 2013

 

IPSO Ventures plc

(to be re-named Plutus Resources plc)

(the "Company")

 

Reduction of Capital effective

 

Further to the announcements made by the Company on, inter alia, 28 December 2012 and 14 January 2013, the Company is pleased to announce that following the confirmation of the Reduction of Capital by the High Court yesterday, the Reduction of Capital has today become effective. Completion of the Proposals remains subject only to admission of the Subscription Shares to trading on AIM.

 

Pursuant to the Proposals, the Company has raised £360,000 (before expenses) through a subscription for 104,000,000 new Ordinary Shares at 0.25p per Ordinary Share and the issue of £100,000 of Convertible Loan Notes convertible into 40,000,000 new Ordinary Shares. Application has been made to the London Stock Exchange for the Subscription Shares to be admitted to trading on AIM and dealings are expected to commence at 8:00 a.m. tomorrow, 1 February 2013.

 

As previously announced, upon Admission, Nicholas Lee will join the Board in the role of Non-Executive Director and John Kelly will step down from the Board. Craig Rochford (currently Chairman) will remain on the board as a Non-Executive Director. Accordingly the Board on Admission will comprise Nicholas Lee (Non-Executive Director) and Craig Rochford (Non-Executive Director). In addition, upon Admission, Charles Tatnall and James Longley, both of whom are Subscribers, will join the Company in non-Board capacities with James Longley acting as Chief Financial Officer and Company Secretary and Charles Tatnall acting as a consultant to the Company. Updated information on the appointment of Nicholas Lee, in accordance with Schedule 2(g) and Rule 17 of the AIM Rules for Companies, is detailed in the appendix below.

 

The Company has applied to the Registrar of Companies to change its name to Plutus Resources plc. A further announcement will be made by the Company with regards to the timing for the Company's change of name and the change of the Company's ticker from "IPS" to "PLR" becoming effective. The ISIN and SEDOL numbers of the Company will not change.

 

Definitions in this announcement are consistent with those set out in the circular issued to Shareholders of the Company on 28 December 2012, a copy of which is available on the investor section of the Company's current website (http://www.ipsoventures.com).

 

For further information, please contact:

 

 

IPSO Ventures plc

Craig Rochford, Chairman

Tel: 020 7462 0093

 

Allenby Capital Limited(Nominated Adviser and Broker)

Mark ConnellyNick Athanas

Tel: 020 3328 5656

 

Appendix - Regulatory Disclosures

 

Nicholas Lee, aged 50, is or has been a director or partner of the following companies during the previous five years:

 

Current directorships or partnerships Directorships or partnerships held in the past five years

 

Paternoster Resources plc WPG Solutions Limited

Brady Exploration plc Paragon Diamonds Limited

Astar Minerals plc Sweet China Limited

ACL Capital Limited Gardener Holdings (Kent) Limited

Boustead Agriculture Limited Novus Capital Markets Limited

Viridas Limited Centurion Resources plc

Leed Resources plc

Nicholas Lee has no direct interest in the issued share capital of the Company. Paternoster Resources plc, a company where Nicholas Lee is Chairman, has subscribed for 40,000,000 of the Subscription Shares at the Subscription Price and £100,000 of the Convertible Loan Notes. On Admission Paternoster Resources plc will be interested in 40,000,000 new Ordinary Shares representing 27.9% of the enlarged issued share capital of the Company on Admission.

 

There are no further disclosures to be made in relation to Nicholas Lee under schedule 2(g) or Rule 17 of the AIM Rules for Companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGFMFMDGFZM
Date   Source Headline
5th Aug 20107:00 amRNSNotice of General Meeting
30th Jul 20107:00 amRNSPreliminary Results 2010
27th Jul 20103:15 pmRNSIssue of Equity
12th Jul 20107:00 amRNSChange of Adviser
25th Jun 20107:00 amRNSTHERAKIND SALE OF INTEREST IN PRODUCT
22nd Jun 20107:00 amRNSIPSO SIGNS COLLABORATION AGREEMENT WITH B1 MEDICAL
12th May 20107:00 amRNSMedermica Files Second Technology Patent
30th Apr 20107:00 amRNSTotal Voting Rights
1st Apr 20109:28 amRNSIssue of New Shares
9th Mar 20107:00 amRNSAXILICA WINS SUBSTANTIAL GRANT
15th Feb 20107:00 amRNSPolyfect enters due diligence agreement
29th Jan 20107:00 amRNSInterim Management Report 2009
14th Jan 20107:00 amRNSIPSol Energy first customer revenues
30th Nov 20097:00 amRNSTotal Voting Rights
6th Nov 200912:19 pmRNSIssue of Shares
6th Nov 200911:39 amRNSDirector's Interest in Shares and Share Options
5th Nov 200910:02 amRNSDirector/PDMR Shareholding
4th Nov 20097:00 amRNSIpso Creates Photovoltaic Testing Business
19th Oct 20097:00 amRNSpH Technology - Development Agreement Signed
15th Oct 20097:00 amRNSTherakind Product Update
11th Sep 20098:42 amRNSResult of AGM
24th Jul 20097:00 amRNSPreliminary Results 2009
8th May 20097:00 amRNSMedermica Files Technology Patent
3rd Apr 20097:00 amRNSSuccessful Fundraising for Therakind
27th Feb 20092:54 pmRNSDirector/PDMR Shareholding
19th Jan 20097:00 amRNSInterim Results
17th Dec 20087:00 amRNSChange of Registered Office
18th Nov 20081:16 pmRNSIssue of New Shares
17th Nov 20084:00 pmRNSAppointment of Joint Broker
4th Nov 20087:00 amRNSAcquisition of Cambridge Meditech
30th Sep 20087:00 amRNSAxilica Limited Update
25th Jul 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSInvestment in Polyfect Soluti
10th Jan 20087:01 amRNSInterim Results
24th Oct 20072:23 pmRNSAnnual Report and Accounts
25th Sep 20077:00 amRNSInvestment in Axilica
10th Sep 20074:10 pmRNSAdditional Listing
20th Aug 20077:02 amRNSRe: AIM Rule 26
25th Jul 20077:00 amRNSFinal Results
17th Jul 200711:47 amRNSDirector/PDMR Shareholding
5th Jul 20077:01 amRNSFurther investment in IWC
15th Jun 20077:00 amRNSTherakind Investment Update
1st Jun 20077:01 amRNSTotal Voting Rights
23rd May 20072:00 pmRNSIssue of Equity
30th Mar 20075:04 pmRNSTotal Voting Rights
21st Mar 200710:45 amRNSHolding(s) in Company
8th Mar 200711:52 amRNSIssue of Equity
7th Mar 20078:05 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.